This site is intended for healthcare professionals only
LoginRegister
Data-Driven scientific studies needed for Antimicrobial Resistance post COVID-19 pandemicData-Driven scientific studies needed for Antimicrobial Resistance post COVID-19 pandemic
DCGI panel to hold discussion on intranasal Five Arms booster dose iNCOVACC on Nov 15: SourcesDCGI panel to hold discussion on intranasal "Five Arms" booster dose iNCOVACC on Nov 15: Sources
Pfizer, BioNTech get positive CHMP opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID vaccine booster for children 5 through 11 years of age in EUPfizer, BioNTech get positive CHMP opinion for Omicron BA.4/BA.5-Adapted Bivalent COVID vaccine...
Pfizer-BioNTech COVID booster targeting Omicron BA.4/5 approved in BritainPfizer-BioNTech COVID booster targeting Omicron BA.4/5 approved in Britain
Monoclonal antibody may help prevent malaria infection in endemic regionMonoclonal antibody may help prevent malaria infection in endemic region
Myocarditis Risk Two-Threefold Higher with Moderna Vaccine than Pfizer: JACC StudyMyocarditis Risk Two-Threefold Higher with Moderna Vaccine than Pfizer: JACC Study
Moderna gets Health Canada authorization for second Omicron -targeting Bivalent boosterModerna gets Health Canada authorization for second Omicron -targeting Bivalent booster
Pfizer-BioNTech to test combined COVID, influenza vaccinePfizer-BioNTech to test combined COVID, influenza vaccine
GSK Depemokimab applications accepted for review in China, Japan for asthma with type 2 inflammation, CRSwNPGSK gets USFDA priority review for RSV older adult vaccine
Biological E Corbevax safe, immunogenic in 5-18 age groupBiological E Corbevax safe, immunogenic in 5-18 age group
GSK Depemokimab applications accepted for review in China, Japan for asthma with type 2 inflammation, CRSwNPGSK marketing authorisation application for RSV older adult vaccine accepted by EMA under...
CanSino Biologics inhalable COVID vaccine introduced in ChinaCanSino Biologics inhalable COVID vaccine introduced in China
X